Past Event

MIT Sloan Health Systems Initiative (HSI) Seminar with Delfi Krishna

USA
11:30AM - 1:00PM ET

When does investing in cell and gene therapy make good business sense?
Thursday April 13, 2023
11:30am - 1pm 
E62-450
Signup at Sloan Groups
In person lunch will be provided 

Join Zoom Meeting
Password: 100
One tap mobile
+16465588656,,93963234492
 
Meeting ID: 939 6323 4492

Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications, in some cases offering the possibility of a disease cure with a single treatment. This presentation will discuss the multi-disciplinary business environment required to bring these cutting-edge medicines to patients.  
 
Delfi Krishna is currently the Vice President of Cell Therapy Portfolio Development at Immatics – a German biotech company with the mission to bring the power of T-cells to cancer patients.  She has a Ph.D in Chemical and Biomolecular Engineering from Georgia Tech and is currently an Executive MBA student at MIT Sloan. 

Delfi Krishna

Delfi Krishna

VP of Cell Therapy Portfolio Development at Immatics

Ph.D, Chemical and Biomolecular Engineering, Georgia Tech

Upcoming Events

to

MBA Class Visit Program

Cambridge Learn More

April 16 Dr. Joachim Nagel, President of Deutsche Bundesbank

Cambridge Learn More

MIT EMBA: Business Analytics Panel

Online Learn More

Thursday, April 18, 2024 - HSI Lunch Seminar Series with Don Rucker, MD, MS Chief Strategy Officer, 1upHealth & former National Coordinator for Health Information Technology (ONC)

Cambridge, MA Learn More